Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 3
2021 1
2022 2
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and treatment of primary biliary cholangitis.
Laschtowitz A, de Veer RC, Van der Meer AJ, Schramm C. Laschtowitz A, et al. Among authors: de veer rc. United European Gastroenterol J. 2020 Jul;8(6):667-674. doi: 10.1177/2050640620919585. Epub 2020 Apr 16. United European Gastroenterol J. 2020. PMID: 32299307 Free PMC article. Review.
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.
de Veer RC, Harms MH, Corpechot C, Thorburn D, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lammers WJ, Hansen BE, van Buuren HR, van der Meer AJ; Global PBC Study Group. de Veer RC, et al. Aliment Pharmacol Ther. 2022 Nov;56(9):1408-1418. doi: 10.1111/apt.17226. Epub 2022 Sep 22. Aliment Pharmacol Ther. 2022. PMID: 36138566 Free PMC article.
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.
de Veer RC, van Hooff MC, Corpechot C, Thorburn D, Invernizzi P, Lammers WJ, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Goet JC, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Hansen BE, Harms MH, van der Meer AJ; Global PBC Study Group. de Veer RC, et al. Am J Gastroenterol. 2023 Jul 1;118(7):1196-1203. doi: 10.14309/ajg.0000000000002128. Epub 2022 Dec 14. Am J Gastroenterol. 2023. PMID: 36621963 Free PMC article.
Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis - an ELTR study.
van Hooff MC, de Veer RC, Karam V, Adam R, Taimr P, Polak WG, Pashtoun H, Murad SD, Corpechot C, Mirza D, Heneghan M, Lodge P, Oniscu GC, Thorburn D, Allison M, Metselaar HJ, den Hoed CM, van der Meer AJ; European Liver and Intestine Transplant Association (ELITA). van Hooff MC, et al. Among authors: de veer rc. JHEP Rep. 2024 Apr 25;6(8):101100. doi: 10.1016/j.jhepr.2024.101100. eCollection 2024 Aug. JHEP Rep. 2024. PMID: 39045337 Free PMC article.
Incidence and prevalence of primary biliary cholangitis in the Netherlands - A nationwide cohort study.
de Veer RC, van Hooff MCB, Werner E, Beuers U, Drenth JPH, Cuperus FJC, van Hoek B, Veldt BJ, Klemt-Kropp M, van Meer S, Verdonk RC, Flink HJ, Vrolijk JM, Gevers TJG, Ponsioen CY, Ter Borg MJ, Soufidi K, Boersma F, de Jonge HJM, Wolfhagen FHJ, Baak LC, Onderwater SL, van Bergeijk JD, van Putten PG, de Bruin GJ, Adang RPR, Aparicio-Pages MN, de Boer W, Borg FT, van Soest H, Janssen HLA, Hansen BE, Erler NS, van der Meer AJ; Dutch PBC Study Group. de Veer RC, et al. JHEP Rep. 2024 Jun 6;6(8):101132. doi: 10.1016/j.jhepr.2024.101132. eCollection 2024 Aug. JHEP Rep. 2024. PMID: 39113899 Free PMC article.
Measurement properties of the PBC-40 and PBC-27: a Dutch validation study.
de Veer RC, da Silva G, van Hooff MC, Harms MH, Metselaar HJ, Willemse J, Utomo E, van der Meer AJ. de Veer RC, et al. BMJ Open Gastroenterol. 2021 Dec;8(1):e000758. doi: 10.1136/bmjgast-2021-000758. BMJ Open Gastroenterol. 2021. PMID: 34916226 Free PMC article.
Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients.
Kreijne JE, de Vries AC, de Veer RC, Bouma G, Dijkstra G, Voskuil MD, West R, van Moorsel SAW, de Jong DJ, de Boer NK, van der Woude CJ; initiative on Crohn and Colitis (ICC). Kreijne JE, et al. Among authors: de veer rc. Aliment Pharmacol Ther. 2020 Jun;51(12):1353-1364. doi: 10.1111/apt.15734. Epub 2020 Apr 28. Aliment Pharmacol Ther. 2020. PMID: 32342997
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis.
Harms MH, de Veer RC, Lammers WJ, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Trivedi PJ, Hirschfield GM, Pares A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Hansen BE, Buuren HRV, van der Meer AJ. Harms MH, et al. Among authors: de veer rc. Gut. 2020 Aug;69(8):1502-1509. doi: 10.1136/gutjnl-2019-319057. Epub 2019 Dec 16. Gut. 2020. PMID: 31843787 Free PMC article.
Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment.
Kreijne JE, de Veer RC, de Boer NK, Dijkstra G, West R, Moorsel SAW, de Jong DJ, van der Woude CJ, de Vries AC; of the Dutch Initiative on Crohn, Colitis (ICC). Kreijne JE, et al. Among authors: de veer rc. Aliment Pharmacol Ther. 2019 Aug;50(4):407-415. doi: 10.1111/apt.15402. Aliment Pharmacol Ther. 2019. PMID: 31359480